Okada M, Shimizu K, Fujii S-i. Identification of neoantigens in cancer cells as targets for immunotherapy. Int J Mol Sci. 2022;23(5):2594.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Her Y, Kim JY, Shin H, Yu K, Lee K-J, Na YR, et al. Tumor neoantigens as key drivers of significant anti-tumor immunity in triple-negative breast cancer mouse models. Neoplasia. 2025;67:101205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pao S-C, Chu M-T, Hung S-I. Therapeutic vaccines targeting neoantigens to induce T-cell immunity against cancers. Pharmaceutics. 2022;14(4):867.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner S, Mullins CS, Linnebacher M. Colorectal cancer vaccines: tumor-associated antigens vs neoantigens. World J Gastroenterol. 2018;24(48):5418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung C-F, Hsu K-F, Cheng W-F, Chai C-Y, He L, Ling M, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res. 2001;61(3):1080–8.

CAS  PubMed  Google Scholar 

Kleijmeer MJ, Escola JM, UytdeHaag FG, Jakobson E, Griffith JM, Osterhaus AD, et al. Antigen loading of MHC class I molecules in the endocytic tract. Traffic. 2001;2(2):124–37.

Article  CAS  PubMed  Google Scholar 

Boudousquié C, Boand V, Lingre E, Dutoit L, Balint K, Danilo M, et al. Development and optimization of a GMP-compliant manufacturing process for a personalized tumor lysate dendritic cell vaccine. Vaccines. 2020;8(1):25.

Article  PubMed  PubMed Central  Google Scholar 

Rittig SM, Haentschel M, Weimer KJ, Heine A, Muller MR, Brugger W, et al. Intradermal vaccinations with RNA coding for TAA generate CD8 + and CD4 + immune responses and induce clinical benefit in vaccinated patients. Mol Ther. 2011;19(5):990–9.

Article  CAS  PubMed  Google Scholar 

Poveda C, Biter AB, Bottazzi ME, Strych U. Establishing preferred product characterization for the evaluation of RNA vaccine antigens. Vaccines. 2019;7(4):131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park H-J, Bang Y-J, Kwon SP, Kwak W, Park S-I, Roh G, et al. Analyzing immune responses to varied mRNA and protein vaccine sequences. NPJ Vaccines. 2023;8(1):84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domazet-Lošo T. mRNA vaccines: why is the biology of retroposition ignored? Genes. 2022;13(5):719.

Article  PubMed  PubMed Central  Google Scholar 

Eftekhari Z, Zohrabi H, Oghalaie A, Ebrahimi T, Shariati FS, Behdani M, et al. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: from delivery systems to clinical applications. Mol Ther. 2024. https://doi.org/10.1016/j.omtn.2024.102313.

Article  Google Scholar 

Zhou W, Jiang L, Liao S, Wu F, Yang G, Hou L, et al. Vaccines’ new era-RNA vaccine. Viruses. 2023;15(8):1760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research advances on the stability of mRNA vaccines. Viruses. 2023. https://doi.org/10.3390/v15030668.

Article  PubMed  PubMed Central  Google Scholar 

Bloom K, van den Berg F, Arbuthnot P. Self-amplifying RNA vaccines for infectious diseases. Gene Ther. 2021;28(3):117–29.

Article  CAS  PubMed  Google Scholar 

Wan J, Wang Z, Wang L, Wu L, Zhang C, Zhou M, et al. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses. mBio. 2023;15(1):e01775–23.

PubMed  PubMed Central  Google Scholar 

Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20(11):817–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther. 2023;8(1):341.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hogan MJ, Pardi N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med. 2022;73(73, 2022):17–39.

Article  CAS  PubMed  Google Scholar 

Ohanube G, Obeta UM. Generation of mRNA vaccine: an analysis of two types of vectors. Int J Pharm Phytopharmacological Res (eIJPPR). 2021;11(4):24–32.

Article  CAS  Google Scholar 

Vallet T, Vignuzzi M. Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development. Viruses. 2025;17(4):566.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni L. Advances in mRNA-based cancer vaccines. Vaccines. 2023;11(10):1599.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang R, Cui J. Advances and applications of RNA vaccines in tumor treatment. Mol Cancer. 2024;23(1):226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong Z, Hu W, Zhou C, Guo J, Yang L, Wang B. Recent advances and perspectives on the development of circular RNA cancer vaccines. NPJ Vaccines. 2025;10(1):41.

Article  PubMed  PubMed Central  Google Scholar 

Xie J, Ye F, Deng X, Tang Y, Liang J-Y, Huang X, et al. Circular RNA: a promising new star of vaccine. J Transl Intern Med. 2023;11(4):372–81.

Article  Google Scholar 

Chen X, Yang T, Wang W, Xi W, Zhang T, Li Q, et al. Circular RNAs in immune responses and immune diseases. Theranostics. 2019;9(2):588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minnaert A-K, Vanluchene H, Verbeke R, Lentacker I, De Smedt SC, Raemdonck K, et al. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across. Adv Drug Deliv Rev. 2021;176:113900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan T, Xu C, Wu J, Cai Y, Cao W, Shen H, et al. Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity. Sci Adv. 2024;10(41):eadn9961.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Ye Z, Huang C, Qiu M, Song D, Li Y, et al. Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 + T cell response. Proc Natl Acad Sci U S A. 2022;119(34):e2207841119.

Article  CAS  PubMed